01 2AMPHASTAR PHARMS INC
02 1LILLY
03 5XERIS
01 2INJECTABLE;INJECTION
02 1POWDER;NASAL
03 5SOLUTION;SUBCUTANEOUS
01 2DISCN
02 6RX
01 1BAQSIMI
02 2GLUCAGON
03 2GVOKE HYPOPEN
04 1GVOKE KIT
05 2GVOKE PFS
01 1No
02 7Yes
RLD : No
TE Code :
Brand Name : GLUCAGON
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 1MG/VIAL
Approval Date : 2020-12-28
Application Number : 208086
RX/OTC/DISCN : RX
RLD : No
TE Code :
RLD : Yes
TE Code :
Brand Name : BAQSIMI
Dosage Form : POWDER;NASAL
Dosage Strength : 3MG
Approval Date : 2019-07-24
Application Number : 210134
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : GLUCAGON
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 1MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1998-09-11
Application Number : 20928
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : GVOKE PFS
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 0.5MG/0.1ML (0.5MG/0.1ML)
Approval Date : 2019-09-10
Application Number : 212097
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : GVOKE PFS
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 1MG/0.2ML (1MG/0.2ML)
Approval Date : 2019-09-10
Application Number : 212097
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : GVOKE HYPOPEN
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 0.5MG/0.1ML (0.5MG/0.1ML)
Approval Date : 2019-09-10
Application Number : 212097
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : GVOKE HYPOPEN
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 1MG/0.2ML (1MG/0.2ML)
Approval Date : 2019-09-10
Application Number : 212097
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : GVOKE KIT
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 1MG/0.2ML (1MG/0.2ML)
Approval Date : 2021-08-20
Application Number : 212097
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
LOOKING FOR A SUPPLIER?
